ORBIMED ADVISORS LLC
111 holdingsFiling period: 2026-03-31Current AUM: $5.67Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | EWTX | EDGEWISE THERAPEUTICS INC | 15.52M | $488.8M | $596.4M | 10.51% | -- | 2026-03-31 |
| 2 | ELVN | ENLIVEN THERAPEUTICS INC | 7.96M | $312.0M | $436.3M | 7.69% | -- | 2026-03-31 |
| 3 | — | MDXHEALTH SA | 124.31M | $285.9M | $285.9M | 5.04% | -- | 2026-03-31 |
| 4 | LLY | ELI LILLY & CO | 236.8K | $217.8M | $272.0M | 4.79% | -64,400 | 2026-03-31 |
| 5 | RCEL | AVITA MEDICAL INC | 82.01M | $197.0M | $234.2M | 4.13% | -- | 2026-03-31 |
| 6 | — | SINOVAC BIOTECH LTD | 2.72M | $184.5M | $184.5M | 3.25% | -- | 2026-03-31 |
| 7 | BSX | BOSTON SCIENTIFIC CORP | 2.38M | $149.5M | $111.3M | 1.96% | -37,200 | 2026-03-31 |
| 8 | SION | SIONNA THERAPEUTICS INC | 3.53M | $141.5M | $166.4M | 2.93% | -30,953 | 2026-03-31 |
| 9 | — | ASTRAZENECA PLC | 670.2K | $132.2M | $132.2M | 2.33% | -- | 2026-03-31 |
| 10 | MYGN | MYRIAD GENETICS INC | 125.00M | $122.9M | $78.1M | 1.38% | -- | 2026-03-31 |
| 11 | MBX | MBX BIOSCIENCES INC | 3.64M | $108.6M | $239.8M | 4.23% | -297,316 | 2026-03-31 |
| 12 | CRVS | CORVUS PHARMACEUTICALS INC | 7.17M | $104.8M | $95.0M | 1.67% | -- | 2026-03-31 |
| 13 | ARGX | ARGENX SE | 136.9K | $100.0M | $116.9M | 2.06% | -9,100 | 2026-03-31 |
| 14 | EW | EDWARDS LIFESCIENCES CORP | 1.23M | $98.5M | $105.9M | 1.87% | -762,300 | 2026-03-31 |
| 15 | ISRG | INTUITIVE SURGICAL INC | 208.7K | $96.2M | $73.7M | 1.30% | -54,700 | 2026-03-31 |
| 16 | CMPX | COMPASS THERAPEUTICS INC | 15.22M | $80.5M | $29.1M | 0.51% | -- | 2026-03-31 |
| 17 | MRK | MERCK & CO INC | 663.4K | $79.8M | $86.4M | 1.52% | -- | 2026-03-31 |
| 18 | GPCR | STRUCTURE THERAPEUTICS INC | 1.48M | $71.1M | $70.9M | 1.25% | +313.6K | 2026-03-31 |
| 19 | AVBP | ARRIVENT BIOPHARMA INC | 3.03M | $69.8M | $90.3M | 1.59% | -- | 2026-03-31 |
| 20 | IRON | DISC MEDICINE INC | 1.07M | $68.3M | $82.2M | 1.45% | -- | 2026-03-31 |
| 21 | SPRY | ARS PHARMACEUTICALS INC | 8.29M | $66.6M | $42.5M | 0.75% | -- | 2026-03-31 |
| 22 | CGON | CG ONCOLOGY INC | 948.3K | $64.2M | $67.5M | 1.19% | -568,283 | 2026-03-31 |
| 23 | XENE | XENON PHARMACEUTICALS INC | 1.06M | $61.6M | $66.4M | 1.17% | +612.8K | 2026-03-31 |
| 24 | SYK | STRYKER CORPORATION | 182.5K | $60.0M | $59.4M | 1.05% | -142,500 | 2026-03-31 |
| 25 | BMY | BRISTOL-MYERS SQUIBB CO | 925.0K | $56.1M | $60.4M | 1.06% | +150.0K | 2026-03-31 |
← Scroll →
Page 1 of 5